Trial intelligence / Profile preview

Conversion from Advagraf to Envarsus for pharmacokinetic monitoring in stable liver transplant recipients

NL-OMON25477Unknown

Sponsor
Leiden University Medical Center
Start
Sep 2017
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of tacrolimus in liver transplant, sponsored by Leiden University Medical Center. Primary endpoints: Population pharmacokinetic parameters of tacrolimus after conversion to Envarsus and Effect of pharmacogenetic polymorphisms on Envarsus pharmacokinetics. Status: unknown.

02

Drugs

tacrolimus
03

Conditions

liver transplant

Beyond the preview

Go deeper on NL-OMON25477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call